10,598 Shares in Revvity, Inc. (NYSE:RVTY) Acquired by Natixis Advisors LLC

Natixis Advisors LLC acquired a new stake in shares of Revvity, Inc. (NYSE:RVTY - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 10,598 shares of the company's stock, valued at approximately $1,111,000.

A number of other large investors also recently bought and sold shares of RVTY. Nomura Asset Management Co. Ltd. acquired a new stake in shares of Revvity during the 4th quarter valued at approximately $3,593,000. BNP Paribas Financial Markets acquired a new stake in shares of Revvity during the fourth quarter worth $12,039,000. Principal Financial Group Inc. bought a new position in shares of Revvity in the 4th quarter worth about $15,213,000. Vanguard Personalized Indexing Management LLC acquired a new position in shares of Revvity in the 4th quarter valued at about $1,160,000. Finally, Commerce Bank bought a new stake in shares of Revvity during the 4th quarter valued at about $1,136,000. Institutional investors own 86.65% of the company's stock.

Insider Buying and Selling

In other news, insider Joel S. Goldberg sold 3,500 shares of the firm's stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total transaction of $412,510.00. Following the completion of the sale, the insider now directly owns 33,400 shares of the company's stock, valued at approximately $3,936,524. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.60% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on RVTY. Wells Fargo & Company began coverage on shares of Revvity in a report on Tuesday, August 27th. They issued an "equal weight" rating and a $130.00 target price on the stock. Bank of America upped their price objective on Revvity from $118.00 to $127.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 30th. JPMorgan Chase & Co. raised their target price on Revvity from $105.00 to $120.00 and gave the company a "neutral" rating in a research note on Tuesday, July 30th. Leerink Partners began coverage on shares of Revvity in a report on Monday, July 8th. They set an "outperform" rating and a $125.00 price target for the company. Finally, Barclays lifted their price objective on shares of Revvity from $115.00 to $125.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 30th. Eight research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $126.00.

Revvity Price Performance

RVTY traded down $0.86 during trading on Thursday, reaching $120.15. The stock had a trading volume of 659,341 shares, compared to its average volume of 841,024. The stock has a 50 day moving average of $116.65 and a two-hundred day moving average of $109.81. The company has a quick ratio of 1.98, a current ratio of 2.27 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $14.83 billion, a price-to-earnings ratio of 100.01, a price-to-earnings-growth ratio of 2.74 and a beta of 1.05. Revvity, Inc. has a 1-year low of $79.50 and a 1-year high of $128.15.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Monday, July 29th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.10. The business had revenue of $691.70 million during the quarter, compared to analyst estimates of $690.33 million. Revvity had a return on equity of 7.34% and a net margin of 6.26%. The company's revenue was down 2.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.21 earnings per share. As a group, equities analysts anticipate that Revvity, Inc. will post 4.75 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 8th. Stockholders of record on Friday, October 18th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.23%. Revvity's dividend payout ratio is currently 23.14%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.